Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Latest, FY2025
8,522
Period ended Dec 31, 2025
Change on a year earlier
+11.9%
7,616 in FY2024
History
20 years
Since FY2006
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash & Cash Equivalents ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8,522 | +11.9% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 7,616 | +10.4% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 6,896 | -30.2% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 9,882 | +0.8% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 9,799 | +43.3% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 6,838 | +77.2% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 3,860 | +0.4% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 3,844 | -59.1% | Form 10-K (filed 2019-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 9,407 | -49.5% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 18,620 | +272.3% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 5,001 | +23.1% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 4,063 | +16.9% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | 3,475 | -67.8% | Form 10-K (filed 2014-02-21) ↗ |
| FY2012 | Dec 31, 2012 | 10,802 | +58.5% | Form 10-K (filed 2014-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 6,813 | +86.8% | Form 10-K (filed 2014-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 3,648 | -58.6% | Form 10-K (filed 2014-02-21) ↗ |
| FY2009 | Dec 31, 2009 | 8,809 | +114.2% | Form 10-K (filed 2010-02-19) ↗ |
| FY2008 | Dec 31, 2008 | 4,112 | +67.4% | Form 10-Q (filed 2009-08-07) ↗ |
| FY2007 | Dec 31, 2007 | 2,456 | +371.4% | Form 10-Q (filed 2009-08-07) ↗ |
| FY2006 | Dec 31, 2006 | 521 | – | Form 10-K (filed 2010-02-19) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Cash & Cash Equivalents ($M) ($M), annual FY2006–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-bs-cash
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.